Tham khảo Điều trị lao tiềm ẩn

  1. Schechter M, Zajdenverg R, Falco G, Barnes G, Faulhaber J, Coberly J, Moore R, Chaisson R (2006). “Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts”. Am J Respir Crit Care Med 173 (8): 922–6. PMC 2662911. PMID 16474028. doi:10.1164/rccm.200512-1953OC
  2. Timothy R. Sterling; M. Elsa Villarino; Andrey S. Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E. Weis; Marc Weiner; Diane Wing; Marcus B. Conde; Lorna Bozeman; C. Robert Horsburgh, Jr.; Richard E. Chaisson (2011). “Three months of rifapentine and isoniazid for latent tuberculosis infection”. New England Journal of Medicine 365: 2155–2166. PMID 22150035. doi:10.1056/NEJMoa1104875
  3. Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. cdc.gov. updated ngày 22 tháng 11 năm 2013.
  4. Clinical trial number NCT01582711 for "Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT (iAdhere)" at ClinicalTrials.gov
  5. 1 2 Menzies, Dick; Al Jahdali, Hamdan; Al Otaibi, Badriah (2011). “Recent developments in treatment of latent tuberculosis infection”. The Indian Journal of Medical Research 133: 257–66. PMC 3103149. PMID 21441678
  6. 1 2 Flynn, J. L.; Chan, J. (2001). “Tuberculosis: Latency and Reactivation”. Infection and Immunity 69 (7): 4195–201. PMC 98451. PMID 11401954. doi:10.1128/IAI.69.7.4195-4201.2001
  7. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ. 1982;60(4):555-64.

Tài liệu tham khảo

WikiPedia: Điều trị lao tiềm ẩn //edwardbetts.com/find_link?q=%C4%90i%E1%BB%81u_tr... //www.ncbi.nlm.nih.gov/pmc/articles/PMC2662911 //www.ncbi.nlm.nih.gov/pmc/articles/PMC3103149 //www.ncbi.nlm.nih.gov/pmc/articles/PMC98451 //www.ncbi.nlm.nih.gov/pubmed/11401954 //www.ncbi.nlm.nih.gov/pubmed/16474028 //www.ncbi.nlm.nih.gov/pubmed/21441678 //www.ncbi.nlm.nih.gov/pubmed/22150035 http://www.ijmr.org.in/text.asp?2011/133/3/257/783... //dx.doi.org/10.1056%2FNEJMoa1104875